ARID2 and cancer: According to the results of the pan-cancer analysis, we found that the abundances of CD4 + T cells and CD8 + T cells were significantly elevated in the mutated ARID1A, mutated ARID1B and mutated ARID2 groups, especially for colorectal cancer and gastric cancer.